Announcements Trials
Browse Landscape

Phase

Phase 1 75Phase 1/2 30Phase NA 28Phase 2 23Phase 3 6Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 14Other 2Gastrointestinal 2Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 76Urinary Bladder Neoplasms 20Neoplasms 11Carcinoma, Transitional Cell 8Non-Muscle Invasive Bladder Neoplasms 6Lung Neoplasms 6Carcinoma, Renal Cell 6Neoplasm Metastasis 5Breast Neoplasms 4Testicular Neoplasms 3Recurrence 3Prostatic Neoplasms, Castration-Resistant 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Kidney Neoplasms 3Colorectal Neoplasms 3Carcinoma in Situ 3Adenocarcinoma 3Acute Kidney Injury 3Uterine Cervical Neoplasms 2Prostate CA 2Melanoma 2Liver Neoplasms 2Kidney Failure, Chronic 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2Critical Illness 2Colonic Neoplasms 2Agnosia 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Endometrial Neoplasms × Genitourinary × Clear all
NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

RenJi Hospital

Phase 2/3 Recruiting
400 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡